全文获取类型
收费全文 | 417篇 |
免费 | 26篇 |
国内免费 | 14篇 |
专业分类
儿科学 | 17篇 |
妇产科学 | 5篇 |
基础医学 | 39篇 |
口腔科学 | 5篇 |
临床医学 | 27篇 |
内科学 | 106篇 |
皮肤病学 | 1篇 |
神经病学 | 23篇 |
特种医学 | 58篇 |
外科学 | 41篇 |
综合类 | 33篇 |
预防医学 | 13篇 |
眼科学 | 2篇 |
药学 | 12篇 |
中国医学 | 1篇 |
肿瘤学 | 74篇 |
出版年
2023年 | 4篇 |
2022年 | 2篇 |
2021年 | 14篇 |
2020年 | 6篇 |
2019年 | 16篇 |
2018年 | 12篇 |
2017年 | 9篇 |
2016年 | 7篇 |
2015年 | 11篇 |
2014年 | 16篇 |
2013年 | 33篇 |
2012年 | 31篇 |
2011年 | 21篇 |
2010年 | 17篇 |
2009年 | 15篇 |
2008年 | 23篇 |
2007年 | 20篇 |
2006年 | 18篇 |
2005年 | 19篇 |
2004年 | 6篇 |
2003年 | 8篇 |
2002年 | 9篇 |
2001年 | 11篇 |
2000年 | 6篇 |
1999年 | 2篇 |
1998年 | 11篇 |
1997年 | 6篇 |
1996年 | 9篇 |
1995年 | 7篇 |
1994年 | 5篇 |
1993年 | 9篇 |
1992年 | 6篇 |
1991年 | 3篇 |
1990年 | 6篇 |
1989年 | 8篇 |
1988年 | 4篇 |
1987年 | 3篇 |
1985年 | 6篇 |
1984年 | 3篇 |
1983年 | 4篇 |
1982年 | 2篇 |
1981年 | 3篇 |
1980年 | 4篇 |
1979年 | 3篇 |
1978年 | 3篇 |
1977年 | 3篇 |
1975年 | 2篇 |
1964年 | 2篇 |
1962年 | 1篇 |
1961年 | 3篇 |
排序方式: 共有457条查询结果,搜索用时 0 毫秒
31.
32.
33.
34.
35.
Demographic changes resulting in ageing of the world's population have major implications for health. As men grow older, circulating levels of the principal androgen or male sex hormone testosterone (T) decline, while the prevalence of ill-health increases. Observational studies in middle-aged and older men have shown associations between lower levels of T and poorer mental health in older men, including worse cognitive performance, dementia and presence of depressive symptoms. The role of T metabolites, the more potent androgen dihydrotestosterone (DHT) and the oestrogen receptor ligand estradiol (E2) in the pathophysiology of cognitive decline are unclear. Studies of men undergoing androgen deprivation therapy in the setting of prostate cancer have shown subtle detrimental effects of reduced T levels on cognitive performance. Randomised trials of T supplementation in older men have been limited in size and produced variable results, with some studies showing improvement in specific tests of cognitive function. Interventional data from trials of T therapy in men with dementia are limited. Lower levels of T have also been associated with depressive symptoms in older men. Some studies have reported an effect of T therapy to improve mood and depressive symptoms in men with low or low-normal T levels. T supplementation should be considered in men with a diagnosis of androgen deficiency. Beyond this clinical indication, further research is needed to establish the benefits of T supplementation in older men at risk of deteriorating cognition and mental health. 相似文献
36.
Viliam Rapcan Shona D’Arcy Sherlyn Yeap Natasha Afzal Jogin Thakore Richard B. Reilly 《Medical engineering & physics》2010,32(9):1074-1079
Currently, there are no established objective biomarkers for the diagnosis or monitoring of schizophrenia. It has been previously reported that there are notable qualitative differences in the speech of schizophrenics. The objective of this study was to determine whether a quantitative acoustic and temporal analysis of speech may be a potential biomarker for schizophrenia.In this study, 39 schizophrenic patients and 18 controls were digitally recorded reading aloud an emotionally neutral text passage from a children's story. Temporal, energy and vocal pitch features were automatically extracted from the recordings. A classifier based on linear discriminant analysis was employed to differentiate between controls and schizophrenic subjects.Processing the recordings with the algorithm developed demonstrated that it is possible to differentiate schizophrenic patients and controls with a classification accuracy of 79.4% (specificity = 83.6%, sensitivity = 75.2%) based on speech pause related parameters extracted from recordings carried out in standard office (non-studio) environments.Acoustic and temporal analysis of speech may represent a potential tool for the objective analysis in schizophrenia. 相似文献
37.
Singapore Indian Eye Study‐2: methodology and impact of migration on systemic and eye outcomes 下载免费PDF全文
38.
39.
40.
Management of corticosteroid-induced osteoporosis 总被引:2,自引:0,他引:2
Corticosteroid (CS) therapy is widely used in the treatment of rheumatic diseases. Osteoporosis remains one of its major complications. The risk of low bone mineral density (BMD) and fracture may be already increased in some of the rheumatic diseases, regardless of CS therapy. However, in spite of this, preventative treatment for osteoporosis in patients on CS remains low. Patients on or about to start CS use for more than 6 months are at risk of corticosteroid-induced osteoporosis (CIOP). The pathogenesis of CIOP differs from post-menopausal osteoporosis in that bone formation is said to be more suppressed compared with bone resorption. The diagnosis of CIOP can be made on clinical risk factors and may not require measurement of BMD. Many agents used in post-menopausal osteoporosis such as activated vitamin D products, hormone replacement therapy, fluoride, calcitonin and the bisphosphonates have been shown to maintain or improve BMD in CIOP. However, there are few data on the reduction in fracture rates in CIOP, but the bisphosphonates seem the most promising in this regard. 相似文献